Laurus Labs has received an approval from United States Food and Drug Administration (USFDA) for Metformin Hydrochloride Tablets USP 500mg, 850mg and 1,000mg which are used for treatment of diabetes.
Metformin Hydrochloride Tablets USP 500mg, 850mg, and 1000mg are therapeutically equivalent to Glucophage Tablets 500mg, 850mg, and 1000 mg of Bristol-Myers Squibb Company. The Product and API will be commercialized from Company's Unit 2 located at APSEZ, Atchutapuram, Visakhapatnam, in the state of Andhra Pradesh.
Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of APIs for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas.
